Shire employee

[anonymous]

Shire employee here. What are the chances of being retained

 

[anonymous]

Shire employee here. What are the chances of being retained

Excellent if you live in Boston area . If you are in the field , crapshoot . If you supported a rare disease product much better chance .

 

[anonymous]

Shire employee here. What are the chances of being retained

Home office- high
NBU- just above zero
GI- zero
Obu- zero
Rare disease- high

We are fucked in the field and if you can’t see that you are a delusional dumb shit

 

[anonymous]

Home office- high
NBU- just above zero
GI- zero
Obu- zero
Rare disease- high

We are fucked in the field and if you can’t see that you are a delusional dumb shit

OBU IS SAFE
No overlap with Takeda roles and unit most likely getting sold to another eye care company. Not going to rock the boat with this group.

 

[anonymous]

OBU IS SAFE
No overlap with Takeda roles and unit most likely getting sold to another eye care company. Not going to rock the boat with this group.

Safe my ass. This BU has more fat and fluff than any.

 

[anonymous]

Shire employee here. What are the chances of being retained

100% dude!

 

[anonymous]

almoat all shire will be retained other than NSS. Vivance is a PC and specialty drug and a Takeda already has that sales force.

 

[anonymous]

almoat all shire will be retained other than NSS. Vivance is a PC and specialty drug and a Takeda already has that sales force.

Sorry about the type for you people that are are so anal about that.

 

[anonymous]

how do you come to this conclusion?

 

[anonymous]

how do you come to this conclusion?

Math

 

[anonymous]

how do you come to this conclusion?

Trust me on this one.

 

[anonymous]

OBU IS SAFE
No overlap with Takeda roles and unit most likely getting sold to another eye care company. Not going to rock the boat with this group.

This is a lie. Safe until sold. OBU will be afterthoughts until then. Seriously, DRY EYE? Nobody cares

 

[anonymous]

OBU will not be retained. At this point it is a small niche part of Takeda that has no reason to put dollars behind it.